# Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.

Study · id `cardio:ct-nct03179514` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03179514](<https://clinicaltrials.gov/study/NCT03179514>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03179514

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT03179514. Randomized; no masking; primary purpose treatment. Start 2017-07 (anticipated); primary completion 2019-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT03179514, source copy `cardio:ctgov-nct03179514-2017-06-07`, retrieved 2026-10-31)
- Planned start: 2017-07 (anticipated) (ClinicalTrials.gov record NCT03179514, source copy `cardio:ctgov-nct03179514-2017-06-07`, retrieved 2026-10-31)
- Primary completion: 2019-10 (anticipated) (ClinicalTrials.gov record NCT03179514, source copy `cardio:ctgov-nct03179514-2017-06-07`, retrieved 2026-10-31)
- Completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT03179514, source copy `cardio:ctgov-nct03179514-2017-06-07`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03179514-2017-06-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.
- Condition: Unstable Angina
- Intervention (Drug): Anti-Platelet Drugs
- Intervention (Drug): Lipid Regulating Drugs
- Intervention (Drug): Coronary Vasodilator
- Intervention (Drug): Gualou Xiebai Banxia Decoction & Danshen Decoction
- Lead sponsor: Jun Li
- Lead sponsor class: OTHER
- Collaborator: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry lists this organization as the lead sponsor: Jun Li (`cardio:org-jun-li`)
- Registry lists this organization as a collaborator: Guang'anmen Hospital of China Academy of Chinese Medical Sciences (`cardio:org-guang-anmen-hospital-of-china-academy-of-chinese-medical-0e53a2`)

## Provenance

Content hash: 4fe3bf863abb64b1e0364b7102380a8ec11d648b47e390fcf5252293f9fa9fd3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
